Arrivo BioVentures is actively pursuing products that fulfill the following criteria:

  • Offer an improvement to patient care that is both clinically and commercially relevant;
  • Have a clear regulatory and development pathway; and
  • Have good prospects for achieving a significant development milestone that could support
    a sale or partnering transaction within four years of our acquisition of rights.